Herantis Pharma Oyj (HEL:HRTIS)
Finland · Delayed Price · Currency is EUR 1.388
-0.022 (-1.56%)
Sep 17, 2026, 6:29 PM EET
Herantis Pharma Oyj Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
36.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 2.06B |
| Terveystalo Oyj | 1.21B |
| Pihlajalinna Oyj | 571.73M |
| Revenio Group Oyj | 124.35M |
| Biohit Oyj | 16.13M |
| Optomed Oyj | 16.10M |
| Modulight Oyj | 9.95M |
| Nanoform Finland Oyj | 5.53M |
Herantis Pharma Oyj News
- 4 weeks ago - Herantis' H1 Loss Narrows As HER-096 Moves Toward Phase 2 For Parkinson's; Stock Down - Nasdaq
- 4 weeks ago - Herantis Pharma Oyj Earnings Call Transcript: H1 2026 - Transcripts
- 4 weeks ago - Herantis Pharma Oyj Quarterly report: H1 2026 - Filings
- 4 weeks ago - Herantis Pharma Oyj Slides: H1 2026 - Filings
- 3 months ago - Herantis Pharma Oyj Slides: Company presentation - Filings
- 3 months ago - Herantis Pharma Oyj Transcript: Study update - Transcripts
- 3 months ago - Herantis Pharma Oyj Press release: Study update - Filings
- 6 months ago - Herantis Pharma Oyj Earnings Call Transcript: H2 2025 - Transcripts